The CRISPR Technology Market was valued at USD 3.8 Billion in 2024, and is expected to reach USD 7.5 Billion by 2029, rising at a CAGR of 14.40%.
This report on CRISPR technology provides market projections for 2029 and analyzes the market for CRISPR technology by application and end user. Applications covered include drug development, agriculture, diagnostics and others. End users include biotechnology and pharmaceutical companies, academics and government research institutes, and contract research organizations.
This report on CRISPR technology provides market projections for 2029 and analyzes the market for CRISPR technology by application and end user. Applications covered include drug development, agriculture, diagnostics and others. End users include biotechnology and pharmaceutical companies, academics and government research institutes, and contract research organizations.
Report Scope
This report on CRISPR technology provides market projections for 2029 and analyzes the market for CRISPR technology by application and end user. Applications covered include drug development, agriculture, diagnostics and others. End users include biotechnology and pharmaceutical companies, academics and government research institutes, and contract research organizations.The report includes:
- 32 data tables and 61 additional tables
- An analysis of the global market for CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) technology
- Analyses of the global market trends, with data from 2021-2022, estimates for 2023, forecast for 2024, and projected CAGRs through 2029
- Discussion of the market potential for CRISPR technology
- Estimate of the market size and a revenue forecast for the global CRISPR technology market, and a corresponding market share analysis by application, end user, and region
- Discussion of the major market dynamics, regulations, industry challenges, and macroeconomic factors that will affect the demand for CRISPR technology market over the next five years
- A look at the recent breakthrough in CRISPR-Cas9 genome editing technology, and how it has propelled the rapid growth in genetic engineering and advanced pharmacological research
- A comparative study on CRISPR with TALE and ZFN nuclease as a gene editing tool and discussion on its higher adaptability over other nucleases
- Review of the patent filings and research publications for innovations in the CRISPR-Cas9 genome editing technology
- A discussion on ESG challenges and ESG practices of the industry participants
- A look at the proprietary technologies and strategic alliances of the companies best positioned in the CRISPR market
- Analysis of the industry structure, competitive landscape, clinical trials, ongoing research activities, and the impact of COVID-19
- Company profiles of the major players, including Merck KGaA, Thermo Fisher Scientific, Beam Therapeutics, CRISPR Therapeutics and Danaher Corp.
Table of Contents
Chapter 1 Executive Summary
Chapter 2 Market Overview
Chapter 3 Market Dynamics
Chapter 4 Emerging Technologies and Developments
Chapter 5 Market Segmentation Analysis
Chapter 6 Competitive Intelligence
Chapter 7 Sustainability in CRISPR Technology: An ESG Perspective
Chapter 8 Appendix
List of Tables
List of Figures
Companies Mentioned
Some of the major companies in the CRISPR Technology market, which are profiled in this report include:- Agilent Technologies Inc.
- Beam Therapeutics
- Caribou Biosciences Inc.
- Crispr Therapeutics
- Danaher Corp.
- Editas Medicine
- Genscript
- Intellia Therapeutics Inc.
- Lonza
- Merck KGaA
- Thermo Fisher Scientific Inc.
Table Information
Report Attribute | Details |
---|---|
No. of Pages | 122 |
Published | October 2024 |
Forecast Period | 2024 - 2029 |
Estimated Market Value ( USD | $ 3.8 Billion |
Forecasted Market Value ( USD | $ 7.5 Billion |
Compound Annual Growth Rate | 14.4% |
Regions Covered | Global |
No. of Companies Mentioned | 11 |